Area of research
Surgery · Oncology
Research interest
Research interests include Medicine, Internal medicine, Pemetrexed, Carboplatin, Hazard ratio, and Biology.
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R Mutation
SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 55position: middle
Efficacy and safety of rhLTα-Da with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-labelled, controlled, phase IIb trial.
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →